UK Medicines Information
New product: Vibativ (telavancin) 750 mg powder for concentrate for solution for infusion
Information type:
Drug prescribing
Source:
Glenmark Pharmaceuticals Europe Ltd
Specialities:
Infection and infectious diseases
Summary
Telavancin is licensed for the treatment of adults with nosocomial pneumonia including ventilator associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus.
UKMi comment
A NICE evidence summary of telavancin is available from the link below.
Related links:
NICE evidence summary